Related Experiment Video
Updated: Jul 17, 2025
MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
Identification and detection of microRNA kidney disease biomarkers in liquid biopsies
Daniel A Smith1,2,3, James E Redman4, Donald J Fraser1,2,3
1Division of Infection & Immunity.
Purpose Of Review:
MicroRNAs (miRNAs) are emerging rapidly as a novel class of biomarkers of major organ disorders, including kidney diseases. However, current PCR-based detection methods are not amenable to development for high-throughput, cost-effective miRNA biomarker quantification.
Recent Findings:
MiRNA biomarkers show significant promise for diagnosis and prognosis of kidney diseases, including diabetic kidney disease, acute kidney injury, IgA nephropathy and delayed graft function following kidney transplantation. A variety of novel methods to detect miRNAs in liquid biopsies including urine, plasma and serum are being developed. As miRNAs are functional transcripts that regulate the expression of many protein coding genes, differences in miRNA profiles in disease also offer clues to underlying disease mechanisms.
Summary:
Recent findings highlight the potential of miRNAs as biomarkers to detect and predict progression of kidney diseases. Developing in parallel, novel methods for miRNA detection will facilitate the integration of these biomarkers into rapid routine clinical testing and existing care pathways. Validated kidney disease biomarkers also hold promise to identify novel therapeutic tools and targets.
Video Abstract:
http://links.lww.com/CONH/A43.
Insights
MicroRNAs (miRNAs) show promise as kidney disease biomarkers. New detection methods are crucial for high-throughput, cost-effective quantification and clinical integration.
Area of Science:
- Biochemistry
- Molecular Biology
- Nephrology
Background:
- MicroRNAs (miRNAs) are increasingly recognized as critical biomarkers for major organ disorders, particularly kidney diseases.
- Current polymerase chain reaction (PCR)-based methods face limitations in high-throughput and cost-effective quantification of miRNA biomarkers.
- Kidney diseases such as diabetic kidney disease, acute kidney injury, IgA nephropathy, and delayed graft function post-transplantation are areas where miRNA biomarkers show significant potential.
Approach:
- Development of novel detection methods for miRNAs in liquid biopsies (urine, plasma, serum).
- Investigating miRNA profiles to understand the underlying mechanisms of kidney diseases.
- Focus on creating high-throughput and cost-effective quantification techniques.
Key Points:
- miRNA biomarkers offer significant promise for the diagnosis and prognosis of various kidney diseases.
- Novel detection techniques are essential for enabling the clinical integration of miRNA biomarkers.
- miRNA profiles provide insights into the molecular mechanisms driving kidney disease progression.
Conclusions:
- Recent advancements underscore the potential of miRNAs as biomarkers for detecting and predicting kidney disease progression.
- The parallel development of novel miRNA detection methods will facilitate their routine clinical use.
- Validated kidney disease biomarkers may also lead to the identification of new therapeutic strategies and targets.
